MEPs adopted the report on new rules governing the use of so-called substances of human origin (SoHO) in the EU, with 483 votes in favour, 52 against and 89 abstentions. The measures apply to substances – such as blood and its components (red/white cells, plasma), tissues and cells – used for transfusions, therapies, transplantations or […]
Read MoreEU steps up action to prevent shortages of antibiotics for next winter
The European Commission, the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) are today issuing recommendations for actions to avoid shortages of key antibiotics used to treat respiratory infections for European patients in the next winter season. These recommendations, which have been developed through the Executive Steering Group on Shortages and Safety […]
Read MoreEU steps up the fight against antimicrobial resistance
The Commission welcomes the adoption by the Council of the European Union of the Commission’s proposal to strengthen EU action against antimicrobial resistance (AMR). Announced together with the Commission’s revision of the pharmaceutical legislation on 26 April, the AMR Recommendation helps combat AMR in the fields of human, animal and environmental health, following the so-called One Health approach. […]
Read MoreEuropean Parliament calls for prudent use of antibiotics and more support for research
Parliament adopted its recommendations on Thursday for a coordinated EU response to health threats posed by antimicrobial resistance. In a resolution passed with 525 votes in favour, two against and 33 abstentions, MEPs say the successful tackling of antimicrobial resistance (AMR) requires the prudent use of antibiotics for humans and animals, good infection prevention and […]
Read MoreCommission secures agreement with BioNTech-Pfizer on the delivery of COVID-19 vaccines
The European Commission, acting with and on behalf of EU Member States through the Health Emergency Preparedness and Response Authority (HERA), and vaccine developers BioNTech-Pfizer, have reached an agreement to better address Member States’ assessment of evolving needs for COVID-19 vaccines. The amendment to the existing vaccines supply contract takes into account the improved epidemiological […]
Read MoreEuropean Commission proposes overhaul of EU pharmaceuticals legislation
The Commission proposes to revise the EU’s pharmaceutical legislation – the largest reform in over 20 years – to make it more agile, flexible, and adapted to the needs of citizens and businesses across the EU. The revision will make medicines more available, accessible and affordable. It will support innovation and boost the competitiveness and attractiveness of the EU pharmaceutical […]
Read MoreEU-UK relations: Commission extends arrangements for veterinary medicines to 2025
The European Commission has today adopted a notice which extends to 31 December 2025 the current arrangements for the movement of veterinary medicines from Great Britain to Cyprus, Ireland, Malta and Northern Ireland. This will ensure the continuity of supplies of veterinary medicinal products, in particular to Northern Ireland. The Commission recognises the key importance of veterinary […]
Read MoreHERA signs Joint Procurement contract COVID-19 treatments
The Commission’s Health Preparedness and Response Authority (HERA) has signed a joint procurement Framework Contract for the supply of Paxlovid, a SARS-CoV-2 protease inhibitor oral treatment for patients with COVID-19 at risk of developing severe disease. The contract is signed with the pharmaceutical company Pfizer and will run for an initial period of 12 months. Thirteen […]
Read MoreHERA secures up to 2 million doses of the monkeypox vaccine
The Commission’s Health Preparedness and Response Authority (HERA), has signed a Joint Procurement Framework contract with the company Bavarian Nordic, for the supply of up to 2 million doses of the monkeypox vaccine in the course of 2023 and 2024. This offers 14 participating countries the possibility to purchase doses to address their medium- and […]
Read More